Blog Archives - Page 67 of 77 - NFCR

Blog

Cancer: There’s an App for That

Here’s a variety of smartphone applications created to specifically address the needs of the cancer community....

Read more

Parasite Killer Too Found to be Effective Cancer Treatment Candidate

Researchers have ascertained that the anti-tapeworm drug, nitazoxanide (NTZ), may also hold out hope as a precision therapy for various cancers. Prostate and colon cancer cells contain high amounts of activated beta-catenin, which correlate to treatment-resistant cancer cells and other oncological parameters. In a study of the cancer-abetting potential of…...

Read more

“System Mistrust” Interferes With Post-Surgery Breast Cancer Treatments

BALTIMORE — A study led by a Johns Hopkins Bloomberg School of Public Health researcher indicates nearly one-third of breast cancer surgery patients went against their doctor’s advice, choosing to not begin or complete adjuvant anti-cancer therapy. The primary factor: a general mistrust of the American healthcare system. Adjuvant therapy…...

Read more

Novel Cancer Genes Discovered Via New Statistical Model

LONDON — A new statistical model developed by scientists at the Francis Crick Institute revealed 27 novel genes thought to prevent cancer from forming, in an analysis of over 2000 tumors across 12 human cancer types. The findings could help create new cancer treatments that target these genes, and open…...

Read more

6 Tips for Staying Healthy During the Holidays

You can follow these simple tips for eating and living healthy this holiday season. Remember: Research links certain cancers to obesity....

Read more

7 Facts You Need to Know About Lung Cancer

With lung cancer affecting the lives of so many people, it’s important to understand the disease and what we can do to improve our chances of beating it....

Read more

NFCR Leads Delegation to Chinese BioMed Conference, Signs MOU with Host

The National Foundation for Cancer Research, led by Chairman Joseph F. Franlin and President Sujuan Ba, recruited a delegation of eight U.S. cancer technology start-ups for a successful exploratory mission to China. The companies—ArrayBio, Eutropics, Immix Biopharma, InterLeukin Therapeutics, International Cancer Impact Fund, InVaMet Therapeutics, Nonpareil Biotechnologies and Stromatis Pharma—were…...

Read more

In the Pink: Preventing Breast Cancer in Every Season of Life

As the tidal wave of pink paraphernalia synonymous with October ebbs, and our thoughts turn to turkey, football and autumn foliage in full Technicolor array; it’s important to keep in mind that preventing breast cancer is a year-round affair. Vigilance is mandatory; that is if preventing and detecting the onset…...

Read more

Outrunning Cancer: Exercise is the Best “Medicine”

Many common cancer treatments and surgeries are invasive and have uncomfortable or painful side-effects which make movement and participation in even the most basic of activities a challenge. Patients are traditionally told to take it easy after being diagnosed or undergoing surgery and treatments. However, a change in school of…...

Read more

Genetic Marker Can Help Focus Prostate Cancer Therapies

CLEVELAND, OH — Two studies conducted by the Cleveland Clinic revealed how a testosterone-related genetic abnormality can help predict individual patient responses to specific prostate cancer therapies. The studies, published in the October 12 issue of JAMA Oncology, suggest that men who inherit this variant would benefit from a personalized…...

Read more